NCT02767258 is a NA clinical trial of LACRIBELL® in Dry Eye Syndromes, sponsored by Diego Dias de Araújo.

Who is sponsoring NCT02767258?

NCT02767258 is sponsored by Diego Dias de Araújo.

What drugs are being tested in NCT02767258?

Interventions in NCT02767258: LACRIBELL®, VIDISIC® GEL.

What condition does NCT02767258 study?

NCT02767258 studies Dry Eye Syndromes.

Is NCT02767258 still recruiting?

NCT02767258 is currently status unknown. Last updated 14 February 2017.

Last reviewed 2017-02-14 · How we verify

NCT02767258

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Nursing Care on Prevention of Dry Eye

Status unknown NA Last updated 14 February 2017

What this trial tests

NA trial testing LACRIBELL® in Dry Eye Syndromes in 300 participants. Status unknown.

Timeline

1 May 2016

Primary endpoint
31 December 2017

31 December 2019

Quick facts

Lead sponsor	Diego Dias de Araújo
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	300
Start date	1 May 2016
Primary completion	31 December 2017
Estimated completion	31 December 2019
Sites	1 location across Brazil

Drugs / interventions tested

LACRIBELL®
VIDISIC® GEL

Conditions studied

Dry Eye Syndromes — all drugs for Dry Eye Syndromes →

Sponsor

Diego Dias de Araújo

Who can join

Adults 18 to 100, any sex, with Dry Eye Syndromes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Clinical trial for prevention, randomized controlled, parallel, double-blind, with three arms, which purpose is verify the nursing interventions (artificial tear gel and liquid artificial tears)effects to prevent dry eye in adult patients admitted in ICU.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Dry Eye Syndromes

Currently open trials in the same condition.

NCT07412860 — Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and Hy · NA · recruiting
NCT06913504 — Comparison Of Blue Light Filter Feature and Blue Blocking Lenses in Digital Device Users With Dry Eye Patients · NA · active not recruiting
NCT06913465 — The Impact of Hypothyroidism on Tear Production and Dry Eye Symptoms: Implications for Optometric Care · active not recruiting
NCT06831253 — Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome · NA · recruiting
NCT06220474 — Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02767258 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Diego Dias de Araújo
Last refreshed: 14 February 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02767258.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing